We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$237M
AUM Growth
+$55.9M
Cap. Flow
+$50.9M
Cap. Flow %
21.44%
Top 10 Hldgs %
68.51%
Holding
729
New
76
Increased
83
Reduced
120
Closed
343

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.93M
2
EFOR
Everforth Inc
EFOR
+$1.81M
3
F icon
Ford
F
+$1.74M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$1.05M
5
XYL icon
Xylem
XYL
+$747K

Sector Composition

Rank Sector Weight
1 Financials 23.74%
2 Consumer Discretionary 10.93%
3 Technology 10.32%
4 Healthcare 4.2%
5 Industrials 3.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHPG
726
DELISTED
Shire pic
SHPG
-3
Closed -$1K
BCR
727
DELISTED
CR Bard Inc.
BCR
-8
Closed -$2K
WWAV
728
DELISTED
The WhiteWave Foods Company
WWAV
-13
Closed -$1K
WOOF
729
DELISTED
VCA Inc.
WOOF
-10
Closed -$1K

Similar funds

Pathstone Family Office's Q2 2017 Portfolio in Review

As of Q2 2017, Pathstone Family Office held 729 positions worth $237M, up 31% from $181M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Pathstone Family Office deployed $50.9M of net new capital in Q2 2017, opening 76 new positions and adding to 83 existing holdings. Its largest new stake was iShares Core High Dividend ETF: 233,470 shares worth $3.88M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $3.93M trimmed.

  • Pathstone Family Office's largest Q2 2017 buy was iShares Core High Dividend ETF: 233,470 shares worth $3.88M.
  • Pathstone Family Office added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $18.4M increase.
  • Pathstone Family Office's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $3.93M.
  • Pathstone Family Office fully exited Ford in Q2 2017, selling an estimated $1.74M.
  • Pathstone Family Office's ten largest holdings make up 69% of its $237M portfolio in Q2 2017.
  • Pathstone Family Office opened 76 new positions and closed 343 in Q2 2017.
  • Pathstone Family Office's portfolio value rose 31% quarter-over-quarter to $237M.

Based on Pathstone Family Office's 13F filing for Q2 2017, filed 11 Aug 2017.